Browsing by Author "Gallo, Juan E."
Now showing items 1-4 of 4
-
Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P2X2
Lopez, Emiliano S.; Ortiz, Gustavo A.; Potilinski, Constanza.; Croxatto, Oscar.; Gallo, Juan E. (Current Eye Research, 2017-12-21)ABSTRACT Purpose: The objective is to analyze the antiangiogenic mechanism of suramab, a pharmaceutical compound of bevacizumab and suramin, in a rabbit model of corneal angiogenesis. Material and Methods: Corneal ... -
Ethical dilemmas associated with clinicians' decisions about treatment in critically ill infants born in Córdoba, Argentina.
Silberberg, Agustin A.; Gallo, Juan E. (SAGE Publications, 2017-01-23)The objective of this article is to examine end of life decisions made by neonatologists of Córdoba, Argentina. An anonymous questionnaire was designed to investigate neonatologists’ decisions on when to initiate or withdraw ... -
Evaluation of the Performance of an Ophthalmic Thermosensitive Hydrogel Containing Combination of Suramin and Bevacizumab.
Quinteros, Daniela A.; Lopez, Emiliano S.; Couto, Juan L.; Maletto, Belkys A.; Allemandi, Daniel A.; Palma, Santiago D.; Gallo, Juan E. (Bentham Science Publishers, 2016)Suramab (SUM) is a new pharmaceutical combination made up of suramine (SUR) and bevacizumab (BVM), which showed a high synergistic effect when administered jointly. As the pharmaceutical vehicle, poloxamer aqueous dispersions ... -
Evaluation of the Performance of an Ophthalmic Thermosensitive Hydrogel Containing Combination of Suramin and Bevacizumab.
Quinteros, Daniela.; Lopez, Emiliano S.; Couto, Juan L.; Maletto, Belkys A.; Allemandi, Daniel A.; Palma, Santiago D.; Gallo, Juan E. (Bentham Science Publishers, 2016)Suramab (SUM) is a new pharmaceutical combination made up of suramine (SUR) and bevacizumab (BVM), which showed a high synergistic effect when administered jointly. As the pharmaceutical vehicle, poloxamer aqueous dispersions ...